Last updated: March 3, 2023
Sponsor: Sun Yat-sen University
Overall Status: Active - Recruiting
Phase
3
Condition
Sinusitis
Mucositis
Treatment
N/AClinical Study ID
NCT05757479
SYSUCC-CMY-2022-sinusitis
Ages 18-70 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- pathologically confirmed nasopharyngeal carcinoma patients
- finished radical radiotherapy (≥66Gy) for at least 3 months
- tumor complete response
- received appropriate medical treatment for sinusitis during or after radiotherapy
- confirmed sinusitis according to European Position Paper on Rhinosinusitis and NasalPolyps 2020
- SNOT-22 ≥ 20 and MRI Lund-Mackay score > 8
- 18-70 years old
Exclusion
Exclusion Criteria:
- anatomic variation resulted in occluded ostiomeatal complex
- Karnofsky score ≤ 70
- life-threatening medical conditions
- tumour residue or recurrence
- acute bacterial sinusitis or acute fungal sinusitis
- cystic fibrosis or primary ciliary dyskinesia
- dependence on prolonged corticosteroid therapy for comorbid conditions
- history of allergy to topical steroids
- pregnant or breastfeeding
Study Design
Total Participants: 168
Study Start date:
February 11, 2023
Estimated Completion Date:
July 01, 2024
Study Description
Connect with a study center
Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center
Guangzhou, Guangdong 510060
ChinaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.